Literature DB >> 16442197

Sub-chronic antipsychotic drug treatment does not alter brain phospholipid fatty acid composition in rats.

Beth Levant1, Jennifer F Crane, Susan E Carlson.   

Abstract

Altered membrane phospholipid fatty acid composition is reported in schizophrenia and appears to be reduced by antipsychotic drug treatment. To determine whether antipsychotic drugs have a direct effect on brain phospholipid fatty acid composition, the effects of sub-chronic treatment with a "typical" and an "atypical" antipsychotic drug were determined in adult male Sprague-Dawley rats. Rats were treated with haloperidol (1 mg/kg), clozapine (20 mg/kg) or vehicle daily for 21 days. Whole brain total phospholipid composition was determined by gas chromatography. No alterations in brain phospholipid composition were produced by either drug. This suggests that the apparent normalization of membrane phospholipids observed in drug-treated schizophrenic patients is not due to a direct pharmacological effect of these drugs nor can the pharmacological effects of these drugs occurring in this time frame be attributed to alterations in neuronal membrane fatty acid composition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16442197     DOI: 10.1016/j.pnpbp.2005.11.034

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  7 in total

1.  Differential effects of modulation of docosahexaenoic acid content during development in specific regions of rat brain.

Authors:  Beth Levant; Marlies K Ozias; Karra A Jones; Susan E Carlson
Journal:  Lipids       Date:  2006-05       Impact factor: 1.880

2.  Differential effects of antipsychotic medications on polyunsaturated fatty acid biosynthesis in rats: Relationship with liver delta6-desaturase expression.

Authors:  Robert K McNamara; Ronald Jandacek; Therese Rider; Patrick Tso; Allyson Cole-Strauss; Jack W Lipton
Journal:  Schizophr Res       Date:  2011-03-31       Impact factor: 4.939

3.  Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications.

Authors:  Robert K McNamara; Ronald Jandacek; Therese Rider; Patrick Tso; Chang-Gyu Hahn; Neil M Richtand; Kevin E Stanford
Journal:  Schizophr Res       Date:  2007-01-19       Impact factor: 4.939

4.  Chronic risperidone treatment preferentially increases rat erythrocyte and prefrontal cortex omega-3 fatty acid composition: evidence for augmented biosynthesis.

Authors:  Robert K McNamara; Jessica A Able; Ronald Jandacek; Therese Rider; Patrick Tso
Journal:  Schizophr Res       Date:  2008-11-07       Impact factor: 4.939

5.  Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients.

Authors:  Ameer Y Taha; Yewon Cheon; Kaizong Ma; Stanley I Rapoport; Jagadeesh S Rao
Journal:  J Psychiatr Res       Date:  2013-02-18       Impact factor: 4.791

6.  Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy.

Authors:  John M Pearce; Richard A Komoroski; Robert E Mrak
Journal:  Magn Reson Med       Date:  2009-01       Impact factor: 4.668

7.  Chronic clozapine reduces rat brain arachidonic acid metabolism by reducing plasma arachidonic acid availability.

Authors:  Hiren R Modi; Ameer Y Taha; Hyung-Wook Kim; Lisa Chang; Stanley I Rapoport; Yewon Cheon
Journal:  J Neurochem       Date:  2012-12-06       Impact factor: 5.372

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.